SCHEMBL9046257

SCHEMBL9046257

Cc1cc(-c2ccccc2)c2c(C#N)c(-c3ccc(C(C)C)cc3Br)[nH]c2n1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 1/20 0.42
CRHR1 P34998 4/20 0.40
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPK1 P28482 1/20 0.36
GAA P10253 1/20 0.36
DYRK1A Q13627 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9046169 0.87 CRHR1 (0.39) KDM4EHSD17B10CRHR1DYRK1A
SCHEMBL9045141 0.86 CRHR1 (0.39) KDM4EALDH1A1CRHR1DYRK1A
SCHEMBL9045363 0.79 CRHR1 (0.37) KDM4ECRHR1
SCHEMBL9045192 0.78 DYRK1A (0.34) KDM4EALDH1A1CRHR1DYRK1A
SCHEMBL9046572 0.75 CRHR1 (0.43) CRHR1
SCHEMBL9047904 0.72 CRHR1 (0.33) KDM4EALDH1A1CRHR1L3MBTL1
SCHEMBL7678511 0.69 CRHR1 (0.41) KDM4EHPGDALDH1A1HSD17B10CRHR1
SCHEMBL9045862 0.63 KDM4E (0.47) KDM4EALDH1A1CRHR1
SCHEMBL7678441 0.63 CRHR1 (0.42) CRHR1
SCHEMBL9047218 0.63 CRHR1 (0.43) KDM4EALDH1A1CRHR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP claimed
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP disclosed